A RANDOMISED, DOUBLE-BLIND, PARALLEL GROUP PHASE III STUDY TO ASSESS THE EFFICACY AND SAFETY OF 100 MG SC DEPEMOKIMAB IN PATIENTS WITH CHRONIC RHINOSINUSITIS WITH NASAL POLYPS (CRSWNP) ¿ ANCHOR-1 (DEPEMOKIMAB IN CHRONIC RHINOSINUSITIS)
- Registry ID
- 217095
- Source registry
- HEALTH_CANADA
- Status
- Ongoing
- Phase
- PHASE3
- Study type
- INTERVENTIONAL
- Sponsor
- GLAXOSMITHKLINE INC
- Start date
- 2023-11-20
- Last update
- 2022-02-09
Conditions
Related clinical trials
- A DOUBLE-BLINDED EXTENSION STUDY TO EVALUATE THE LONG-TERM SAFETY AND TOLERABILITY OF ITEPEKIMAB IN ADULT PARTICIPANTS WITH INADEQUATELY CONTROLLED CHRONIC RHINOSINUSITIS WITH NASAL POLYPS (CRSWNP) WHO PARTICIPATED IN EITHER EFC18418 OR EFC18419 CLINICAL STUDIES
- THE EFFICACY OF INTRA-SINUS POVIDONE-IODINE/BUDESONIDE GEL FORMING SUSPENSION FOLLOWING ENDOSCOPIC SINUS SURGERY FOR CHRONIC RHINOSINUSITIS: A RANDOMIZED, DOUBLE BLIND, PLACEBO-CONTROLLED TRIAL
- A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUP, 52-WEEK PHASE 3
TRIAL TO INVESTIGATE THE EFFICACY, SAFETY, AND TOLERABILITY OF ITEPEKIMAB IN ADULT
PARTICIPANTS WITH INADEQUATELY-CONTROLLED CHRONIC RHINOSINUSITIS WITH NASAL POLYPS
- A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUP, 52-WEEK PHASE 3
TRIAL TO INVESTIGATE THE EFFICACY, SAFETY, AND TOLERABILITY OF ITEPEKIMAB IN ADULT
PARTICIPANTS WITH INADEQUATELY-CONTROLLED CHRONIC RHINOSINUSITIS WITH NASAL POLYPS
- OPENING THE 'BLACK BOX' ON TEZEPELUMAB'S EFFECT OF CHRONIC RHINOSINUSITIS WITH SEVERE ASTHMA
- A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PROOF-OF-CONCEPT (POC) STUDY TO
ASSESS THE EFFICACY, SAFETY, AND TOLERABILITY OF ITEPEKIMAB IN PARTICIPANTS WITH
INADEQUATELY CONTROLLED CHRONIC RHINOSINUSITIS WITHOUT NASAL POLYPS
View on source registry